Regulatory Issues

Featured Article

Drawing the Line Between Personal Beliefs and Patient Rights

Drawing the Line Between Personal Beliefs and Patient Rights

There's only one way to resolve the dissonance between personal beliefs and professional obligations: remembering that physicians take an oath pledging fealty to patients' health, not their own belief systems.

Latest

Republican Opposition to Obamacare: What's Done, What's to Come

Republican Opposition to Obamacare: What's Done, What's to Come

Republicans who have fought against the Affordable Care Act (ACA) for years are at a crossroads after their opposition largely failed.

Steps Taken to Increase Use of Electronic Tools in Medicine

Steps Taken to Increase Use of Electronic Tools in Medicine

Additional codes have been approved by the Current Procedural Terminology Editorial Panel for chronic care remote physiologic monitoring and internet consultations.

FDA Approval of Medication With a Digital Monitoring System: Major Breakthrough or "Brave New World"?

FDA Approval of Medication With a Digital Monitoring System: Major Breakthrough or "Brave New World"?

Abilify MyCite adds a digital sensor to the medication aripiprazole. The sensor, an ingestible event marker, is activated by contact with stomach acids and transmits a signal to a skin patch the patient wears, which then transmits to an app.

AMA Proposes Policy Opposing Medicaid 'Lockout' Provisions

AMA Proposes Policy Opposing Medicaid 'Lockout' Provisions

A new policy opposing lockout provisions that block Medicaid patients from the program for lengthy periods and instead supporting allowing patients to reapply immediately for redetermination was adopted by the American Medical Association House of Delegates during the AMA's annual meeting in Chicago, according to an article published in the association's AMA Wire.

FDA Taps Social Media to Identify and Assess Emerging Drug Abuse Threats

FDA Taps Social Media to Identify and Assess Emerging Drug Abuse Threats

The FDA continues to battle the nation's opioid problem even as it looks to detect and prevent the next threat.

Marijuana's Uncertain Status: Closing the Gap Between State and Federal Policies

Marijuana's Uncertain Status: Closing the Gap Between State and Federal Policies

Senator Elizabeth Warren introduced a bipartisan bill in June 2018 (S.3032) that would exempt most marijuana-related activities from the Controlled Substances Act when they are allowed under state or tribal law.

New Short-Term Health Plans Have Large Coverage Gaps

New Short-Term Health Plans Have Large Coverage Gaps

There are large coverage gaps in short-term health plans that were approved Wednesday by the Trump administration.

The Halford Case Controversy: Are Institutional Review Board Regulations Too Strict?

The Halford Case Controversy: Are Institutional Review Board Regulations Too Strict?

William Halford, PhD, reportedly administered a live attenuated herpes simplex virus vaccine to 17 participants at an off-campus hotel without approval from an institutional review board.

Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions

Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions

In the United States, legalization of medical cannabis on a statewide basis was associated with a nearly 30% decrease in schedule III (but not schedule II) opioid prescription numbers and dosages for Medicaid patients.

Groups Urge CMS to Reconsider Suspending Risk Adjustment

Groups Urge CMS to Reconsider Suspending Risk Adjustment

Twenty-eight medical organizations, including AMA, sent letter to Administrator Verma of CMS